Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Headache and electroconvulsive therapy

S J Weiner1, T N Ward, C L Ravaris

  • 1Dartmouth Medical School, Chicago, IL.

Headache
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The "resident's dilemma"? Values and strategies of medical residents for education interactions: a cellular automata simulation.

Methods of information in medicine·2006
Same author

Secondary cluster headache: a presentation of cerebral venous thrombosis.

Cephalalgia : an international journal of headache·2006
Same author

From research evidence to context: the challenge of individualising care.

Equine veterinary journal·2006
Same author

Headache in giant cell arteritis and other arteritides.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2005
Same author

Migraine-tic syndrome: a case report of a new headache type.

Cephalalgia : an international journal of headache·2003
Same author

Rathke's cleft cyst as a secondary cause of headache:a case report.

Cephalalgia : an international journal of headache·2002
Same journal

Biochemical profiling and symptomatology of androgen deficiency in males with cluster headache: A prospective case-control study.

Headache·2026
Same journal

Thiamine deficiency in patients with chronic migraine: A case-control study.

Headache·2026
Same journal

Potential association of cluster headache with certain COVID-19 vaccines: An assessment from the pharmacovigilance databases.

Headache·2026
Same journal

Potential role of tirzepatide, a dual GLP-1 and GIP receptor agonist, for preventive treatment of migraine: A case series.

Headache·2026
Same journal

Adverse childhood experiences, migraine, and adverse pregnancy outcomes among teenage mothers.

Headache·2026
Same journal

Weight loss with atogepant in the long-term treatment of migraine: An interim analysis of a safety endpoint from a phase 3, multicenter, open-label, 156-week extension study.

Headache·2026
See all related articles

Electroconvulsive therapy (ECT) can cause headaches, potentially due to its effect on serotonin receptors. This study explored headache changes in patients undergoing ECT, finding a tendency towards migrainous headaches post-treatment.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Headache is a known side effect of electroconvulsive therapy (ECT), but its mechanisms are poorly understood.
  • Both ECT and antidepressant drugs modulate serotonergic neurotransmission, but differ in their effects on 5-hydroxytryptamine (5-HT) type 2 receptors.
  • ECT upregulates 5-HT2 receptors, while antidepressants downregulate them; 5-HT2 receptor sensitization is linked to headache genesis.

Observation:

  • A retrospective survey of 54 patients who underwent ECT was conducted.
  • Patients reported new onset headaches, exacerbation of existing headaches, or improvement in headaches following ECT.
  • Headache characteristics sometimes changed, with a progression from tension-type to migrainous headaches, persisting long-term.

Findings:

Related Experiment Videos

  • Five patients reported new headaches post-ECT, four had worsening headaches, and two experienced improvement.
  • A shift in headache type towards migrainous features was observed in some patients.
  • These headache alterations persisted for at least eight months in most affected patients.

Implications:

  • The findings suggest a link between ECT-induced 5-HT2 receptor upregulation and headache development.
  • Understanding these mechanisms could inform strategies to manage or prevent ECT-associated headaches.
  • Further research is warranted to elucidate the precise relationship between ECT, serotonin receptors, and headache pathophysiology.